Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Exome Sequencing Could Improve Success Of Kidney Transplants

XTALKS VITALS NEWS

Organ

The study – which was published in the journal, PLOS Computational Biology – uses a genetic matching program incorporating many genes to help physicians predict long-term transplantation success.

Tweetables from this article:

Tweet: Up to 50 percent of all #kidneytransplants still fail within a decade of surgery
http://buff.ly/2cZjLTP Up to 50 percent of all kidney transplants still fail within a decade of surgery.

Share this!

September 30, 2016 | by Sarah Hand, M.Sc.

Researchers at Weil Cornell Medicine in New York have developed a novel DNA-based scoring system to predict matches between kidney donors and recipients, thereby potentially improving transplant success. The study – which was published in the journal, PLOS Computational Biology – uses a genetic matching program incorporating many genes to help physicians predict long-term transplantation success.

Doctors currently use DNA sequence data to compare organ donors to their prospective recipients. The more similarities in key genes between the patients, the greater the chance that a transplant will be a success. Unfortunately, up to 50 percent of all kidney transplants still fail within a decade of surgery, suggesting other areas of genomic compatibility are important to consider.

“There is a striking shortage of kidneys for transplantation worldwide, and a major contributor to the shortage are patients with a failed kidney transplant who return to the transplant wait list,” said Dr. Manikkam Suthanthiran, Professor of Medicine at Weil Cornell Medicine, and one of the study’s co-authors. “Should our novel scoring system be validated in future clinical trials, a real opportunity could emerge for minimizing the disparity between organ supply and demand.”



By collecting DNA data from a broader selection of genes from 53 sets of kidney donors and recipients, the researchers studied the influence of many genes on transplant success. Based on mismatches in the exome of the transplant donor and recipient, the researchers developed a computation method to allocate a score to each pair.

In order to test the applicability of these scores to patient outcomes, the researchers followed-up with kidney donors and recipients for many years after the initial transplant surgery. The score generated from the whole exome sequencing program was found to be a significant predictor of the transplant kidney’s functionality after surgery.

“Future studies will be able to build on this new concept to confirm the initial observations,” said Dr. Fabien Campagne, Assistant Professor of Research in Computational Biomedicine at Weil Cornell Medicine, and the senior author on the study. “They may lead to using this new concept in the clinic to optimize the matching of donor and recipients before transplantation.”


Keywords: Organ Transplant, Exome Sequencing, Genomics


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News


Targeting Cellular Nitrogen Metabolism Could Offer a New Treatment for Pancreatic Cancer

August 17, 2017 - An enzyme involved in regulating the amount of nitrogen in the cell could be a new drug target for pancreatic cancer, according to researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard.

Featured In: Life Science News


Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

One Patient’s Perspective on Clinical Trials

REGISTER FOR THESE WEBINARS

Planning and Conducting Trials of the Latest Immunotherapies


ISO 13485:2016 for Medical Device Manufacturers: Ensuring a Smooth Transition through Effective Preparation


Medical Devices: Reviewing Regulatory Changes in the US and EU


Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.